Investor FAQs

Investor FAQs

Where is Progyny’s Headquarters?

Our headquarters are located at:
1359 Broadway, 2nd Floor
New York, NY 10018

When was Progyny’s IPO?

Our shares began trading on October 25, 2019.

Where are Progyny’s shares traded and under what symbol?

Our shares are traded on the Nasdaq Global Market under the symbol “PGNY”.

Does Progyny have a direct stock purchase plan? How do I purchase shares?

We do not offer a direct stock purchase plan. Shares can be purchased through a stockbroker of your choice.

Who is Progyny’s transfer agent?

Our transfer agent is Computershare.
You may contact them through their website at, or by writing to them at:


Mailing Address:                                                
P.O. Box 43006                                             
Providence, RI 02940-3006                         

Where can I get a copy of your Annual Report?

You may visit our SEC Filings page for our quarterly and annual reports as well as other materials. Filings may also be accessed directly from the SEC’s website at

When does Progyny release its financial results?

You may visit our Events page to find information about upcoming results. You may also subscribe to our Email Alerts to receive updates.

Who is Progyny’s independent auditor?

Our independent auditor is Ernst & Young LLP.

When is Progyny’s fiscal year end?

Our fiscal year ends on December 31st.

What is Progyny’s dividend policy?

We have never declared or paid cash dividends on our capital stock. We currently intend to retain all available funds and future earnings, if any, to fund the development and expansion of our business, and we do not anticipate paying any cash dividends in the foreseeable future.

Who can I contact with questions?

Please email your questions to Investor Relations at